Educational information, not medical advice — ask your doctor or midwife.
Habb-e-Bukhar is a classical multi-herb compound from the Unani system of medicine, one of the world's oldest codified medical traditions rooted in Greco-Arabic and South Asian practice. The name literally means 'fever tablet' — Habb means pill or tablet, and Bukhar means fever in Urdu and Arabic. It has been prescribed by Unani physicians (Hakims) for centuries as a first-line remedy for fevers of various origins, including malarial, bilious, and seasonal fevers.
The formula works through a combination of antipyretic, anti-inflammatory, diaphoretic (sweat-inducing), and antimicrobial actions supplied by its herbal constituents. Ingredients like neem, Tinospora cordifolia, and quinine bark are thought to lower body temperature by supporting the immune response and reducing inflammatory signaling. Camphor and black pepper help promote sweating and improve circulation, which Unani theory views as essential for breaking a fever and clearing pathogenic heat from the body.
Habb-e-Bukhar is most commonly dispensed as small round tablets (habb) from Unani pharmacies and manufacturers. Some traditional Hakims also prepare it as a powder or decoction. Commercial preparations are available from licensed Unani pharmaceutical companies in South Asia and are increasingly available online globally.
Habb-e-Bukhar appears in classical Unani pharmacopoeias including the National Formulary of Unani Medicine (NFUM) published by the Indian government. It traces its lineage to Greco-Arabic medicine codified by Ibn Sina (Avicenna) in the 11th century and adapted through centuries of South Asian practice. It remains a widely used OTC Unani medicine across India, Pakistan, and Bangladesh.
Evidence grades and traditional-use labels are explained in our methodology. Nothing here is medical advice.
Reviewed by the HealisticMD editorial team How we grade evidence →
The published evidence for Habb-e-Bukhar is weak or absent. That usually means no controlled trial has tested it, not that a trial found it ineffective — the two are different, and we grade only what has been published.
What it is typically used for, usual dose, cautions, and the study behind it where real trial data exists.
One email with the summary. We'll also send a short weekly evidence update — unsubscribe any time.